UMC Q2 earnings beat expectations, but pricing power remains unproven

What happened

United Microelectronics reported second-quarter results exceeding analyst estimates, with revenue rising 8.4% year-over-year and margins expanding, boosted by record 22-nanometer sales. The performance aligns with management’s earlier guidance of low single-digit USD ASP growth and utilization in the low-80% range, confirming a stabilization trend. However, the margin improvement is primarily mix-driven, reflecting higher-value node contributions rather than a broad-based pricing reset, as the company’s previously announced 2H26 price increase letters have yet to show up in realized pricing. This release, from late July 2026, does not alter the fundamental concern that the market is pricing in a rapid ASP upcycle that remains unconfirmed. The beat provides incremental evidence of a gradual recovery but falls short of validating the structural pricing power needed to justify UMC’s current valuation multiples.

Implication

Investors should view this result as in-line with the base-case stabilization scenario, not a catalyst for re-rating. Margin expansion still relies on mix shifts (record 22nm sales) rather than realized pricing leverage across the portfolio. Until audited filings show flat or rising YoY ASP, the risk of a de-rating toward the mid-$20s remains. The positive earnings surprise may lift near-term sentiment but does not resolve the core concern that current multiples discount a swift pricing upcycle. We therefore maintain a cautious stance, and would only consider adding exposure on a pullback toward the $20–$24 range where the risk/reward becomes more attractive.

Thesis delta

The Q2 report matches our base-case expectations, offering no new evidence that the 2H26 price increase letters have converted into realized pricing gains. The thesis that UMC’s stock is overvalued relative to an unconfirmed ASP recovery remains unchanged. While margin expansion is encouraging, it is driven by higher-value mix rather than the broad pricing leverage required to support current valuations.